[Dysmorphisms and psychomotor retardation in infants of mothers treated with anticonvulsants in pregnancy].
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008260:Macroglossia / Q000139:chemically induced; D009666:Nose / Q000002:abnormalities; D010634:Phenobarbital / Q000009:adverse effects* / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011596:Psychomotor Disorders / Q000139:chemically induced; D012886:Skull / Q000002:abnormalities; D014034:Toes / Q000002:abnormalities
D000927:Anticonvulsants; D010672:Phenytoin; D010634:Phenobarbital
Dismorfismi e ritardo psicomotorio in soggetto nato da nadre trattata con anticonvulsivanti in gravidanza.